Merge widens net loss, passes on strategic alternatives

Healthcare IT and advanced visualization developer Merge Healthcare reported a small increase in revenues but a bigger net loss in its fourth quarter.

For the period (end-December 31), Merge had net sales of $64.7 million, up almost 1% from the $64.1 million reported in the fourth quarter of 2011. The company had a net loss of $17.3 million, compared with a net loss of $1.3 million a year ago.

In other quarterly news, Merge said that its subscription-based pricing arrangements generated 13.5% of total quarterly sales. Subscription backlog increased 13% in the fourth quarter and 82% for the year.

The company also reiterated its 2013 guidance of sales ranging from $265 million to $275 million, with an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) range of 22% to 24% and expected subscription backlog growth to least $25 million.

Merge also said that it has completed its previously announced evaluation of strategic alternatives and has concluded that the alternatives did not offer more value than its own strategic plan.

Page 1 of 775
Next Page